Spark Investment Management LLC Exelixis, Inc. Transaction History

Spark Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$18.93 - $24.75 $863,208 - $1.13 Million	-45,600 Closed	0 $0
Q1 2019 May 07, 2019	SELL	$19.6 - $24.76 $1.97 Million - $2.49 Million	-100,700 Reduced 68.83%	45,600 $1.09 Million
Q4 2018 Feb 12, 2019	SELL	$13.65 - $21.8 $2.5 Million - $4 Million	-183,400 Reduced 55.63%	146,300 $2.88 Million
Q2 2018 Aug 08, 2018	BUY	$18.56 - $22.45 $1.6 Million - $1.94 Million	86,400 Added 35.51%	329,700 $7.1 Million
Q1 2018 May 10, 2018	BUY	$22.15 - $31.89 $5.39 Million - $7.76 Million	243,300 New	243,300 $5.39 Million

501

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.2B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.